EE254 Biosimilars Impact on the Rheumatoid Arthritis Treatment: A Cost-Effectiveness Model from Spanish National Healthcare System Perspective
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.502
https://www.valueinhealthjournal.com/article/S1098-3015(22)00703-3/fulltext
Section Title :
Section Order :
10447
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00703-3&doi=10.1016/j.jval.2022.04.502